ProBio
@ProBioTrial
ProBio is an outcome-adaptive, multi-arm, open-label, multiple assignment randomized biomarker driven trial in patients with metastatic prostate cancer
ID:1088057129129385984
http://probiotrial.org 23-01-2019 12:53:29
48 Tweets
129 Followers
0 Following
#ProBio , a randomized, outcome-adaptive, biomarker-driven platform trial: AR pathway inhibitors or taxanes for patients with #mCRPC : a direct comparison. Presentation by Henrik Grönberg Karolinska Institutet. #ESMO23 coverage by Zach Klaassen > bit.ly/3tJOTTD ProBio
🔵 ProBio Trial Insights: mCRPC Treatment
🔵Biomarker-driven treatment approach for mCRPC.
🔵 Directly randomized data reveal ARPi’s significant superiority in both PFS and OS over other treatments in mCRPC scenario.
ESMO - Eur. Oncology OncoAlert #ESMO23 Oncology Brothers UroToday.com Uromigos…
📣Exciting #MedOnc #urology news!
Join us at #ESMO23 for the first ProBio #Clinicaltrial results 👀
🗓️22.10.2023
⏰09:15
📍Granada Auditorium - Hall 3
📈 Using 🩸🧬 liquid biopsy for AR pathway inhibitors vs. taxanes in metastatic castration-resistant #ProstateCancer
📣Exciting #MedOnc #urology news!
Join us at #ESMO23 for the first ProBio #Clinicaltrial results 👀
🗓️22.10.2023
⏰09:15
📍Granada Auditorium - Hall 3
📈 Using 🩸🧬 liquid biopsy for AR pathway inhibitors vs. taxanes in metastatic castration-resistant #ProstateCancer
Finally! The ProBio assay developed by my team Karolinska Institutet and SciLifeLab is finally implemented as a routine diagnostic test Karolinska Univ.sjuk .
news.ki.se/from-lab-to-ho…
